Biocogniv Inc

Biocogniv Inc is a healthcare AI company based in Burlington/South Burlington, Vermont, founded in 2019.

The company focuses on developing digital diagnostics for hospitals and acute care settings, utilizing artificial intelligence to analyze routine laboratory data. This approach aims to identify critical conditions earlier than traditional methods. The core platform, clinOS, is a cloud-based clinical data system that supports various products and integrates with hospital workflows. One of its key offerings is Sepsis aiMarkerTM, which detects and predicts sepsis using emergency room lab panels and has received FDA Breakthrough Designation. Biocogniv also offers interpAssistTM, an automated platform for interpreting complex lab tests, and is working on additional AI markers for conditions like respiratory failure and acute heart failure. Biocogniv's services cater to hospitals, emergency departments, and healthcare systems, providing predictive diagnostics and real-time lab interpretation. The company has established connections with multiple hospital systems in the U.S., processing thousands of lab tests daily. Notable partners include UTMB Health, North Country Hospital, and San Joaquin Hospital, with UTMB's COVID-19 program highlighted as being powered by Biocogniv technology.